Loading…
Loading…
EQUITY / IEX · IEXG
Endovia Health Sciences, Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗0.1757 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 0.1757 USD · Volume 421,820
680 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Cash and cash equivalents | 242,702 USD | — | — |
| Net income | -2,054,787 USD | -8,493,081 USD | — |
| Operating profit | -2,007,366 USD | -1,501,991 USD | — |
| Total assets | 1,076,332 USD | — | — |
| Total equity | -15,749,045 USD | -11,281,919 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 242,702 USD | — | — | 281,435 USD | 281,435 USD | 265,667 USD | — | — |
| Net incomeIncome statement | -2,054,787 USD | -4,191,256 USD | -2,136,469 USD | — | -25,234,834 USD | -9,886,045 USD | -22,029,577 USD | -8,493,081 USD |
| Operating profitIncome statement | -2,007,366 USD | -2,986,336 USD | — | — | -14,186,220 USD | -9,544,679 USD | -13,209,809 USD | -1,501,991 USD |
| Total assetsBalance sheet | 1,076,332 USD | — | — | 965,694 USD | 965,694 USD | 22,489,297 USD | — | — |
| Total equityBalance sheet | -15,749,045 USD | — | -16,203,284 USD | -15,300,828 USD | -15,300,828 USD | 6,777,552 USD | — | -11,281,919 USD |
| Total liabilitiesBalance sheet | 16,825,377 USD | — | — | 16,266,522 USD | 16,266,522 USD | 15,711,745 USD | — | — |
| Financing cash flowCash flow statement | — | 2,209,103 USD | — | — | 5,104,137 USD | — | 4,126,295 USD | — |
| Gross profitIncome statement | — | 1,848 USD | — | — | 16,898 USD | — | -30,443 USD | — |
| Investing cash flowCash flow statement | — | -204,553 USD | — | — | — | — | — | — |
| Operating cash flowCash flow statement | — | -2,022,172 USD | — | — | -4,820,018 USD | — | -3,828,797 USD | — |
| RevenueIncome statement | — | 4,224 USD | — | — | 73,066 USD | — | 438,272 USD | — |
| Report source | Open report ↗ Published: 08/19/2026 | Open report ↗ Published: 08/19/2026 | Open report ↗ Published: 08/19/2026 | Open report ↗ Published: 08/19/2026 | Open report ↗ Published: 04/15/2026 | Open report ↗ Published: 11/19/2025 | Open report ↗ Published: 11/19/2025 | Open report ↗ Published: 08/19/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.